gene therapy - search results

New research by the National Institutes of Health challenge common practice of increasing doses at early signs of worsening symptoms in asthma

Grazina Berry from Aplastic Anaemia Trust, along with Professor Judith Marsh and Dr Shreyans Gandhi from King’s College Hospital NHS Foundation Trust, explore the rare and serious condition of aplastic anaemia (AA)

Jonathan Evans, communications manager at the Association of British Healthcare Industries explains the need to innovate when it comes to using digital technologies for the delivery of healthcare in the UK.

New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...

Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease From the time it was first described in the mid-nineteenth century, the cause and treatment of Pernicious Anaemia became the subject of some of the most inquisitive...

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...

Cecilia Van Cauwenberghe from Frost & Sullivan explores advancing opportunities for personalised treatment of chronic kidney disease (CKD) and research into membranous nephropathy (MN) According to The National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, in the US alone, approximately 30 million adults are estimated to...

Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...

Ellen Rowles from Action PR highlights how local community leisure centres play a key role in rehabilitation and ease the burden on GPs A growing amount of evidence has shown that the average workload for GPs has increased 16% over the past seven years resulting in GPs resigning at a...

Matthieu JABAUDON from Université Clermont Auvergne unveils his thoughts on distinct acute respiratory distress syndrome (ARDS) morphotypes based on lung imaging patterns It has long been recognised that acute respiratory distress syndrome (ARDS) is a clinical syndrome with marked heterogeneity in its presentation and clinical course (see www.openaccessgovernment.org/acute-respiratory-distress-syndrome-2/34971). One approach to...

Roberta Savli from EFA provides insight into allergic rhinitis Rhinitis is a very common disorder, far more than just sneezing a couple of days in the year. Allergic rhinitis is a serious chronic respiratory disease that reduces patients’ quality of life and their productivity at work and at school. Despite...

Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...

The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug Experts believe that the new experimental drug, which is injected into spinal fluid, could be the biggest breakthrough in neurodegenerative diseases for 50 years. The unstoppable death of brain cells in Huntington's gradually causes...

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a comprehensive overview of sensory processing disorder (SPD) in children today Children with sensory processing disorder or dysfunction (SPD) are characterised by the occurrence of inward information in very atypical, diverting modes. Energising diagnosis and treatment through multi-sensory behaviour and activity...

Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice In the UK, evidence that pharmacists can provide better clinical outcomes and more efficient, consistent and sustainable services for patients, is increasing. In this article, key themes are discussed to showcase...

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer